Latest Breaking News On - Syneos health clinical - Page 1 : comparemela.com

Saama Appoints Ian Holmes, Ph.D., to Swiss Board of Directors Posted Jan 14, 2021 Saama Appoints Ian Holmes, Ph.D., to Swiss Board of Directors   Wide spectrum of pharma and CRO experience Extensive global clinical trial operations and management expertise   CAMPBELL, CA – (January 14, 2021) – Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, announced today that Ian Holmes, Ph.D., has joined its Swiss Board of Directors, effective January 1, 2021. Based in Zurich, Dr. Holmes brings over 40 years of drug research and development experience and expertise to Saama’s European presence.   Most recently Dr. Holmes held the position of Senior Vice President of Corporate Development at the CRO PharmaNet, now Syneos Health Clinical. As a member of the PharmaNet Global Executive Committee, he was charged with effecting the geographical expansion and globalization of the company, with emphasis on Europe, Asia, Australasia, an

United statesIan holmesSaama saamatechincDirectorsposted janSuresh kattaGregoryt simpsonClinical research europe atGh besselaar associatesCorning pharmaceutical servicesPharmanet global executive committeeCorporate developmentSyneos health clinicalSaama technologies incAppoints ian holmesSwiss boardSenior vice president